Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017312 · ClinicalTrials.gov registry record · NA
A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting
A NA study, sponsored by Hill-Rom.
- Terminated
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT04017312: Clinical Trial NA study, sponsored by Hill-Rom.
NCT04017312 is a NA study that was terminated before completion, run by Hill-Rom. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04017312, a NA study, was terminated before completion, sponsored by Hill-Rom.
- TERMINATED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This a 70 patient multi-site non blinded randomized control trial evaluating the use of the Vest® System for treatment of Non-Cystic Fibrosis Bronchiectasis (NCFBE) patients in the home setting. The study will assess outcomes in subjects requiring airway clearance therapy randomized to Oscillating Positive Expiratory Pressure (OPEP) therapy as the control group and High Frequency Chest Wall Oscillation (HFCWO) therapy as the intervention group
Primary Outcome
Acute exacerbation periods will be defined as per the European Respiratory Society consensus definition: * A deterioration in three or more of the following key symptoms for at least 48 h: * Cough * Sputum volume and/or consistency * Sputum purulence * Breathlessness and/or exercise tolerance * Fatigue and/or malaise; * Hemoptysis AND * A clinician determines that a change in bronchiectasis treatment is required
Interventions
- DEVICE High Frequency Chest Wall Oscillation
- DEVICE Oscillating Positive Expiratory Pressure (OPEP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2024-08-06 |
| Phase | NA |
Why NCT04017312 stopped before completion
NCT04017312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which High Frequency Chest Wall Oscillation is the first listed.
NCT04017312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04017312 about?
NCT04017312 is a clinical study titled "A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting". This a 70 patient multi-site non blinded randomized control trial evaluating the use of the Vest® System for treatment of Non-Cystic Fibrosis Bronchiectasis (NCFBE) patients in the home setting. The study will assess outcomes in subjects requiring airway clearance therapy randomized to Oscillating P...
What is the current status of trial NCT04017312?
This trial is currently terminated. It is a NA study. The enrollment target is 43 participants. The study started on 2019-08-23. Estimated completion is 2024-08-06.
What interventions are being tested in trial NCT04017312?
The interventions under investigation include: High Frequency Chest Wall Oscillation (DEVICE), Oscillating Positive Expiratory Pressure (OPEP) (DEVICE).
Who is sponsoring clinical trial NCT04017312?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04017312's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI